Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|March 7, 2018
Common presentation of rare cardiac diseases: ArrhythmiasIacopo Olivotto, Gherardo Finocchiaro, Niccolò Maurizi, et al.
Pharmacological Research|December 7, 2019
β-blockers: Their new life from hypertension to cancer and migraineCarlo Fumagalli, Niccolò Maurizi, Niccolò Marchionni, et al.
Heart Failure Clinics|March 12, 2018
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical TrialsNiccolò Maurizi, Enrico Ammirati, Raffaele Coppini, et al.
European Heart Journal. Case Reports|September 11, 2024
Accelerated hypertension following mavacamten introduction in severe obstructive hypertrophic cardiomyopathy with hypertension: a case reportNiccolò Maurizi, Panagiotis Antiochos, Olivier Muller, et al.
Heart (British Cardiac Society)|April 16, 2025
Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysisAdil Salihu, Panagiotis Antiochos, Henri Lu, et al.
The Canadian Journal of Cardiology|August 28, 2025
Gene Replacement Therapy in Cardiac Diseases: challenges in trial design and management of adverse eventsNiccolò Maurizi, Kimberly N Hong, Elizabeth Silver, et al.
International Journal of Cardiology|December 13, 2022
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school childrenNiccolò Maurizi, Carlo Fumagalli, Ioannis Skalidis, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|August 27, 2025
Healthcare access, symptom burden, and psychological impact in hypertrophic cardiomyopathy: a multinational patient-driven surveyEmil Tsenov, Jolanda Van der Velden, Matteo Pinciroli, et al.
Nature Reviews. Cardiology|November 11, 2016
Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic diseaseGiovanni Quarta, Michael Papadakis, Paolo Di Donna, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026
Incidence, Timing and Clinical Significance of Adverse Immune Events after Gene Replacement Therapy: a Systematic Review and Meta-AnalysisNiccolò Maurizi, Enrico Ammirati, Elizabeth Silver, et al.
Pageof 4